Symbol: GSK Sector: Healthcare Industry: Drug Manufacturers
Update: 2019-06-09 12:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2019-03-31 |
7,661,000,000 |
7,661,000,000 |
2,733,000,000 |
4,928,000,000 |
3,500,000,000 |
1,428,000,000 |
830,000,000 |
- |
- |
n.a. |
- |
4,419,000,000 |
- |
- |
- |
372,000,000 |
663,000,000 |
1,006,000,000 |
Update: 2019-06-09 12:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2018-12-31 |
8,197,000,000 |
8,197,000,000 |
2,904,000,000 |
5,293,000,000 |
2,158,000,000 |
3,135,000,000 |
1,215,000,000 |
16,927,000,000 |
58,066,000,000 |
54,394,000,000 |
4,360,000,000 |
4,087,000,000 |
5,793,000,000 |
3,958,000,000 |
26,064,000,000 |
460,000,000 |
4,119,000,000 |
1,076,000,000 |
2018-09-30 |
8,092,000,000 |
8,092,000,000 |
2,636,000,000 |
5,456,000,000 |
3,546,000,000 |
1,910,000,000 |
1,418,000,000 |
17,418,000,000 |
58,604,000,000 |
54,881,000,000 |
4,476,000,000 |
3,587,000,000 |
2,902,000,000 |
3,873,000,000 |
27,710,000,000 |
-100,000,000 |
2,077,000,000 |
988,000,000 |
2018-06-30 |
7,310,000,000 |
7,310,000,000 |
2,310,000,000 |
5,000,000,000 |
4,221,000,000 |
779,000,000 |
441,000,000 |
17,044,000,000 |
57,635,000,000 |
54,612,000,000 |
3,679,000,000 |
3,685,000,000 |
3,470,000,000 |
4,127,000,000 |
28,062,000,000 |
-90,000,000 |
1,362,000,000 |
925,000,000 |
2018-03-31 |
7,222,000,000 |
7,222,000,000 |
2,391,000,000 |
4,831,000,000 |
3,591,000,000 |
1,240,000,000 |
549,000,000 |
- |
- |
n.a. |
- |
3,757,000,000 |
- |
- |
- |
209,000,000 |
863,000,000 |
904,000,000 |
Update: 2019-06-09 12:40:01
Report Date |
Operating Revenue |
Total Revenue |
Cost of Revenue |
Gross Profit |
Operating Expense |
Operating Income |
Net Income |
Current Assets |
Total Assets |
Total Liabilities |
Shareholders Equity |
Current Cash |
Current Debt |
Total Cash |
Total Debt |
Cash Change |
Cash Flow |
R&D |
2017-12-31 |
10,322,970,289 |
10,322,970,289 |
3,456,755,858 |
6,866,214,431 |
3,506,755,845 |
3,359,458,586 |
-737,837,646 |
21,495,940,357 |
76,190,520,731 |
71,475,657,092 |
-91,891,868 |
4,864,863,600 |
3,817,566,575 |
5,285,133,761 |
23,093,237,239 |
-977,026,773 |
3,877,026,019 |
1,633,783,359 |